Late additionSecondary

SK Capital Partners, Bain Capital Life Sciences acquire Swixx Biopharma

Switzerland

SourcingClub was not involved in this transaction.

Mérieux Equity Partners has completed the sale of a majority of its shares in Swixx Biopharma to SK Capital Partners and Bain Capital Life Sciences. Swixx Biopharma was a portfolio company of Mérieux Participations 4.

Deal-Radar editorial team · responsible:

late addition, source dated 02 Jun 2026: merieux-partners.com

How the deal fits together.

  1. Mérieux Equity Partners (Mérieux Participations 4)Seller
  2. Target: Swixx Biopharma
  3. Buyer: SK Capital Partners, Bain Capital Life Sciences

Who was involved.

Target
Swixx Biopharma
Seller
Mérieux Equity Partners (Mérieux Participations 4)
Type
Secondary
Country
Switzerland
Source dated
02/06/2026

Deal-Radar no. 47-208 · added in Week 47/2026, first reported on 02/06/2026 · publicly reported, no guarantee · SourcingClub was not involved in this transaction. Report an error · Sources and limits

We report publicly announced information and link the source; we accept no liability for its accuracy. No offer and no investment, legal or tax advice. The operators of linked pages are responsible for their content. We correct errors as soon as we learn of them.

June 2026 on the Deal-Radar.

4 of 21 deals were of the type Secondary.

  1. Buy-out8
  2. Add-on4
  3. Secondary4
  4. Strategic4
  5. Carve-out1

New deals every day. By email on Mondays.

All deals of the previous week in one email, with source and adviser.

Weekly email every Monday, in German.

Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 21 November 2026.